Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change

Psychopharmacology

Volumn 229, Issue 2, 2013, Pages 307-321

  Tanda, Gianluigi ^a   Li, Su Min ^a   Mereu, Maddalena ^a   Thomas, Alexandra M ^a   Ebbs, Aaron L ^a   Chun, Lauren E ^a   Tronci, Valeria ^a   Green, Jennifer L ^a   Zou, Mu Fa ^a   Kopajtic, Theresa A ^a   Newman, Amy Hauck ^a   Katz, Jonathan L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Accumbens shell; Benztropine analogs; Cocaine; Dopamine microdialysis; Dopamine transporter conformation; Drug abuse; Place preference

Indexed keywords

2 ALPHA CARBOETHOXY 3 [BIS(4 CHLOROPHENYL)METHOXY]TROPANE; 2 ALPHA CARBOMETHOXY 3 [BIS(4 CHLOROPHENYL)METHOXY]TROPANE; 4' CHLORO 3 ALPHA (DIPHENYLMETHOXY)TROPANE; 4' CHLORO 4'' CHLORO 3 ALPHA (DIPHENYLMETHOXY)TROPANE; BENZATROPINE; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING KINETICS; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG BINDING SITE; DRUG EFFECT; MALE; MAMMAL; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVE STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE CONDITIONING; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; RADIOASSAY; RADIOLIGAND BINDING ASSAY; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BENZTROPINE; BINDING SITES; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84883462310     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3109-6     Document Type: Article

References (49)

1. Balster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:119-29
2. Bruner A (1969) Reinforcement strength in classical conditioning of leg flexion, freezing, and heart rate in cats. Cond Reflex 4:24-31
3. Campbell VC, Kopajtic TA, Newman AH, Katz JL (2005) Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. J Pharmacol Exp Ther 315:631-40
4. Chen N, Reith ME (2004) Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential. J Neurochem 89:750-65
5. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-108
6. De Beun R, Jansen E, Geerts NE, Slangen JL, Van de Poll NE (1992) Temporal characteristics of appetitive stimulus effects of luteinizing hormone-releasing hormone in male rats. Pharmacol Biochem Behav 42:445-50
7. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, Katz JL (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-93
8. Desai RI, Paronis CA, Martin J, Desai R, Bergman J (2010) Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther 333:834-43
9. Dworkin SI, Smith JE (1988) Neurobehavioral pharmacology of cocaine. NIDA Res Monogr 88:185-98
10. Garces-Ramirez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G (2011) Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry 69:208-17
11. Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL (2011) Decreases in Cocaine Self-Administration with Dual Inhibition of the Dopamine Transporter and sigma Receptors. J Pharmacol Exp Ther 339:662-77
12. Hiranita T, Soto PL, Newman AH, Katz JL (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329:677-86
13. Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113:939-55
14. Katz JL, Izenwasser S, Kline RH, Allen AC, Newman AH (1999) Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288:302-15
15. Katz JL, Libby TA, Kopajtic T, Husbands SM, Newman AH (2003) Behavioral effects of rimcazole analogues alone and in combination with cocaine. Eur J Pharmacol 468:109-19
16. Kopajtic TA, Liu Y, Surratt CK, Donovan DM, Newman AH, Katz JL (2010) Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. J Pharmacol Exp Ther 335:703-14
17. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
18. Li SM, Kopajtic TA, O'Callaghan MJ, Agoston GE, Cao J, Newman AH, Katz JL (2011) N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. J Pharmacol Exp Ther 336:575-85
19. Li SM, Newman AH, Katz JL (2005) Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats. J Pharmacol Exp Ther 313:1223-30
20. Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813-23
21. Loland CJ, Norregaard L, Litman T, Gether U (2002) Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc Natl Acad Sci U S A 99:1683-8
22. National Research Council (2003) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, DC
23. Newman AH, Katz JL (2008) The benztropines: atypical dopamine-uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter. In: Trudell ML, Izenwasser S (eds) Dopamine Transporters, Chemistry, Biology, and Pharmacology. Wiley, New York, pp 171-210
24. Newman AH, Katz JL (2009) Atypical dopamine uptake inhibitors that provide clues about cocaine's mechanism at the dopamine transporter. Topics in Medicinal Chemistry 4:95-129
25. Newman AH, Kline RH, Allen AC, Izenwasser S, George C, Katz JL (1995) Novel 4'-substituted and 4',4'-disubstituted 3 alpha-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. J Med Chem 38:3933-40
26. Pavlov IP (1927) Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Oxford University Press, London, Translated and Edited by G.V. Anrep
27. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, Sydney
28. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the «shell» as compared with the «core» of the rat nucleus accumbens. Proc Natl Acad Sci U S A 92:12304-8
29. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-7
30. Reith ME, Ali S, Hashim A, Sheikh IS, Theddu N, Gaddiraju NV, Mehrotra S, Schmitt KC, Murray TF, Sershen H, Unterwald EM, Davis FA (2012) Novel C-1 substituted cocaine analogs unlike cocaine or benztropine. J Pharmacol Exp Ther 343:413-25
31. Reith ME, Berfield JL, Wang LC, Ferrer JV, Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-8
32. Ritz MC, Boja JW, George FR, Kuhar MJ (1989) Cocaine binding sites related to drug self-administration. NIDA Res Monogr 95:239-46
33. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-23
34. Runyon SP, Carroll FI (2008) Tropane-based dopamine transporter-uptake inhibitors. In: Trudell ML SI (ed) Dopamine Transporters, Chemistry, Biology, and Pharmacology. Wiley, New York, pp 125-170
35. Samaha AN, Li Y, Robinson TE (2002) The rate of intravenous cocaine administration determines susceptibility to sensitization. The J of Neurosci: The Official J of the Soc for Neurosci 22:3244-50
36. Samaha AN, Mallet N, Ferguson SM, Gonon F, Robinson TE (2004) The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. The J of Neurosci: The Official J of the Soc for Neurosci 24:6362-70
37. Schmitt KC, Zhen J, Kharkar P, Mishra M, Chen N, Dutta AK, Reith ME (2008) Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. J Neurochem 107:928-40
38. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119:376-84
39. Tanda G, Ebbs A, Newman AH, Katz JL (2005) Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313:613-20
40. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, Katz JL (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-44
41. Tanda G, Katz JL (2007) Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. Pharmacol Biochem Behav 87:400-4
42. Tanda G, Kopajtic TA, Katz JL (2008) Cocaine-like neurochemical effects of antihistaminic medications. J Neurochem 106:147-57
43. Tanda G, Newman A, Ebbs AL, Tronci V, Green J, Tallarida RJ, Katz JL (2009a) Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther 330:802-809
44. Tanda G, Newman AH, Katz JL (2009b) Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. Adv Pharmacol 57:253-89
45. Tanda G, Pontieri FE, Di Chiara G (1997a) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048-50
46. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997b) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-85
47. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JB Jr (1995) Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120:10-20
48. Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154:375-82
49. Zou MF, Cao J, Kopajtic T, Desai RI, Katz JL, Newman AH (2006) Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation. J Med Chem 49:6391-9